Annual D&A
$11.00 K
-$113.00 K-91.13%
March 1, 2024
Summary
- As of February 8, 2025, GRCE annual depreciation & amortization is $11.00 thousand, with the most recent change of -$113.00 thousand (-91.13%) on March 1, 2024.
- During the last 3 years, GRCE annual D&A has fallen by -$913.00 thousand (-98.81%).
- GRCE annual D&A is now -99.53% below its all-time high of $2.33 million, reached on March 1, 2019.
Performance
GRCE Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$2000.00
+$1000.00+100.00%
September 1, 2024
Summary
- As of February 8, 2025, GRCE quarterly depreciation & amortization is $2000.00, with the most recent change of +$1000.00 (+100.00%) on September 1, 2024.
- Over the past year, GRCE quarterly D&A has increased by +$1000.00 (+100.00%).
- GRCE quarterly D&A is now -99.75% below its all-time high of $794.10 thousand, reached on March 1, 2019.
Performance
GRCE Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$5000.00
$0.000.00%
September 1, 2024
Summary
- As of February 8, 2025, GRCE TTM depreciation & amortization is $5000.00, unchanged on September 1, 2024.
- Over the past year, GRCE TTM D&A has dropped by -$13.00 thousand (-72.22%).
- GRCE TTM D&A is now -99.80% below its all-time high of $2.51 million, reached on December 1, 2019.
Performance
GRCE TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
GRCE Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -91.1% | +100.0% | -72.2% |
| 3 y3 years | -98.8% | +103.3% | -95.3% |
| 5 y5 years | -99.5% | -99.6% | -98.7% |
GRCE Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -98.8% | -100.0% | -98.8% | +103.3% | -97.0% | +113.9% |
| 5 y | 5-year | -99.5% | -100.0% | -99.7% | +103.3% | -99.8% | +113.9% |
| alltime | all time | -99.5% | -100.0% | -99.8% | +103.3% | -99.8% | +113.9% |
Grace Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2000.00(+100.0%) | $5000.00(0.0%) |
| Jun 2024 | - | $1000.00(0.0%) | $5000.00(-54.5%) |
| Mar 2024 | $11.00 K(-91.1%) | $1000.00(0.0%) | $11.00 K(-38.9%) |
| Dec 2023 | - | $1000.00(-50.0%) | $18.00 K(-33.3%) |
| Sep 2023 | - | $2000.00(-71.4%) | $27.00 K(-175.0%) |
| Jun 2023 | - | $7000.00(-12.5%) | -$36.00 K(-129.0%) |
| Mar 2023 | $124.00 K(>+9900.0%) | $8000.00(-20.0%) | $124.00 K(+6.9%) |
| Dec 2022 | - | $10.00 K(-116.4%) | $116.00 K(+9.4%) |
| Sep 2022 | - | -$61.00 K(-136.5%) | $106.00 K(-36.5%) |
| Jun 2022 | - | $167.00 K(>+9900.0%) | $167.00 K(>+9900.0%) |
| Mar 2022 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2021 | - | $0.00(0.0%) | $1000.00(0.0%) |
| Sep 2021 | - | $0.00(0.0%) | $1000.00(-99.7%) |
| Jun 2021 | - | $0.00(-100.0%) | $376.00 K(-59.3%) |
| Mar 2021 | $924.00 K(-60.2%) | $1000.00(>+9900.0%) | $924.00 K(-39.3%) |
| Dec 2020 | - | $0.00(-100.0%) | $1.52 M(-28.1%) |
| Sep 2020 | - | $375.00 K(-31.6%) | $2.12 M(-7.8%) |
| Jun 2020 | - | $548.00 K(-8.7%) | $2.30 M(-0.9%) |
| Mar 2020 | $2.32 M(-0.6%) | $600.00 K(+0.7%) | $2.32 M(-7.7%) |
| Dec 2019 | - | $596.00 K(+7.6%) | $2.51 M(+5.0%) |
| Sep 2019 | - | $554.00 K(-2.8%) | $2.39 M(+0.5%) |
| Jun 2019 | - | $570.00 K(-28.2%) | $2.38 M(+2.1%) |
| Mar 2019 | $2.33 M(+12.8%) | $794.10 K(+66.8%) | $2.33 M(+15.9%) |
| Dec 2018 | - | $476.20 K(-12.2%) | $2.01 M(-2.1%) |
| Sep 2018 | - | $542.60 K(+4.3%) | $2.06 M(-1.0%) |
| Jun 2018 | - | $520.10 K(+9.6%) | $2.08 M(+0.3%) |
| Mar 2018 | $2.07 M(+0.8%) | $474.60 K(-8.6%) | $2.07 M(+29.8%) |
| Dec 2017 | - | $519.10 K(-7.7%) | $1.59 M(+5.3%) |
| Sep 2017 | - | $562.50 K(+9.7%) | $1.51 M(+6.7%) |
| Jun 2017 | - | $512.90 K(+17.0%) | $1.42 M(-21.5%) |
| Mar 2017 | $2.05 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2016 | - | $438.20 K(-6.2%) | $1.81 M(-0.1%) |
| Aug 2016 | - | $467.30 K(+0.1%) | $1.81 M(+2.7%) |
| May 2016 | - | $466.90 K(+7.7%) | $1.76 M(-0.3%) |
| Feb 2016 | $1.77 M(-5.3%) | $433.50 K(-1.7%) | $1.77 M(+5.8%) |
| Nov 2015 | - | $440.90 K(+5.0%) | $1.67 M(-0.8%) |
| Aug 2015 | - | $420.00 K(-11.2%) | $1.69 M(-6.5%) |
| May 2015 | - | $473.00 K(+40.3%) | $1.80 M(-3.4%) |
| Feb 2015 | $1.87 M(+17.1%) | $337.20 K(-25.9%) | $1.87 M(+0.2%) |
| Nov 2014 | - | $455.20 K(-15.2%) | $1.86 M(-8.5%) |
| Aug 2014 | - | $537.10 K(+0.1%) | $2.03 M(+3.2%) |
| May 2014 | - | $536.70 K(+61.3%) | $1.97 M(+23.6%) |
| Feb 2014 | $1.59 M(+145.4%) | $332.80 K(-47.0%) | $1.59 M(+13.2%) |
| Nov 2013 | - | $627.50 K(+32.6%) | $1.41 M(+48.5%) |
| Aug 2013 | - | $473.10 K(+194.2%) | $948.60 K(+46.2%) |
| May 2013 | - | $160.80 K(+9.2%) | $649.00 K(-0.1%) |
| Feb 2013 | $649.60 K(-3.3%) | $147.20 K(-12.1%) | $649.50 K(-5.7%) |
| Nov 2012 | - | $167.50 K(-3.5%) | $689.00 K(+3.5%) |
| Aug 2012 | - | $173.50 K(+7.6%) | $665.50 K(+0.5%) |
| May 2012 | - | $161.30 K(-13.6%) | $662.20 K(-1.4%) |
| Feb 2012 | $671.80 K(-2.0%) | $186.70 K(+29.7%) | $671.80 K(-1.1%) |
| Nov 2011 | - | $144.00 K(-15.4%) | $679.00 K(-4.6%) |
| Aug 2011 | - | $170.20 K(-0.4%) | $711.60 K(+1.9%) |
| May 2011 | - | $170.90 K(-11.9%) | $698.20 K(+1.9%) |
| Feb 2011 | $685.30 K(+7868.6%) | $193.90 K(+9.8%) | $685.30 K(+38.3%) |
| Nov 2010 | - | $176.60 K(+12.6%) | $495.40 K(+54.6%) |
| Aug 2010 | - | $156.80 K(-0.8%) | $320.50 K(+94.0%) |
| May 2010 | - | $158.00 K(+3850.0%) | $165.20 K(+1798.9%) |
| Feb 2010 | $8600.00 | $4000.00(+135.3%) | $8700.00(+85.1%) |
| Nov 2009 | - | $1700.00(+13.3%) | $4700.00(+56.7%) |
| Aug 2009 | - | $1500.00(0.0%) | $3000.00(+100.0%) |
| May 2009 | - | $1500.00 | $1500.00 |
FAQ
- What is Grace Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Grace Therapeutics?
- What is Grace Therapeutics annual D&A year-on-year change?
- What is Grace Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Grace Therapeutics?
- What is Grace Therapeutics quarterly D&A year-on-year change?
- What is Grace Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Grace Therapeutics?
- What is Grace Therapeutics TTM D&A year-on-year change?
What is Grace Therapeutics annual depreciation & amortization?
The current annual D&A of GRCE is $11.00 K
What is the all time high annual D&A for Grace Therapeutics?
Grace Therapeutics all-time high annual depreciation & amortization is $2.33 M
What is Grace Therapeutics annual D&A year-on-year change?
Over the past year, GRCE annual depreciation & amortization has changed by -$113.00 K (-91.13%)
What is Grace Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of GRCE is $2000.00
What is the all time high quarterly D&A for Grace Therapeutics?
Grace Therapeutics all-time high quarterly depreciation & amortization is $794.10 K
What is Grace Therapeutics quarterly D&A year-on-year change?
Over the past year, GRCE quarterly depreciation & amortization has changed by +$1000.00 (+100.00%)
What is Grace Therapeutics TTM depreciation & amortization?
The current TTM D&A of GRCE is $5000.00
What is the all time high TTM D&A for Grace Therapeutics?
Grace Therapeutics all-time high TTM depreciation & amortization is $2.51 M
What is Grace Therapeutics TTM D&A year-on-year change?
Over the past year, GRCE TTM depreciation & amortization has changed by -$13.00 K (-72.22%)